Completed OBSERVATIONAL NCT01961102

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Pilot-study of OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Sponsor: Krankenhaus Barmherzige Schwestern Linz

Conditions Atypical Hyperplasia Endometrial Cancer

Interventions hysteroscopy/curettage in case of suspicious aspect will be done a rapid section

Updated 6 times since 2017 Last updated: Aug 7, 2016 Started: May 31, 2013 Primary completion: Sep 30, 2015 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01961102, this observational or N/A phase trial focuses on Atypical Hyperplasia and Endometrial Cancer and remains completed. Sponsored by Krankenhaus Barmherzige Schwestern Linz, it has been updated 6 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Krankenhaus Barmherzige Schwestern Linz

Data source: Krankenhaus Barmherzige Schwestern Linz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Linz, Austria